Drug
rivaroxaban
Marketed as XARELTO.
Generic name
rivaroxaban
Brand names
XARELTO
First FDA approval
2011-07-01
Drug class
Direct oral anticoagulants (DOACs)
Patient assistance program
Xarelto Cares
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215859 | XARELTO | 2021-12-20 | JANSSEN PHARMS |
| NDA022406 | XARELTO | 2011-07-01 | JANSSEN PHARMS |
Manufacturers
JANSSEN PHARMS
Common denial patterns
- Step therapy requiring warfarin first
- Non-formulary
Specific notes
Brand: Xarelto.
Manufacturer patient assistance
Xarelto Cares: https://www.xarelto.com
Frequently asked questions
Why does insurance commonly deny rivaroxaban?
Step therapy requiring warfarin first; Non-formulary.
When was rivaroxaban FDA approved?
Earliest FDA approval on record: 2011-07-01.
What brand names are sold as rivaroxaban?
XARELTO.
Is there a patient assistance program for rivaroxaban?
Yes — Xarelto Cares at https://www.xarelto.com.
What's specific to rivaroxaban?
Brand: Xarelto.
Related
Sources
Appeal a rivaroxaban denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com